China's early South American soybean buys squeeze US out of peak export window
Advertisement
The shift underscores Beijing's growing trade reliance on South America and comes amid renewed political and commercial tensions with Washington.
According to market analysis from Brazil's Safras & Mercado, traders reported Chinese purchases of roughly 8 million tonnes of soybeans for September and 4 million tonnes for October, about half of the country's projected demand for the two months. All volumes are sourced from South America, with Brazil capturing the lion's share.
The move effectively shortens the US 'window' for soybean shipments to China, which typically runs from September to January before the Brazilian harvest arrives.
Last year, China imported 105 million tonnes of soybeans, 22.13 million of them from the US, illustrating how pivotal this early-season slot has been for American farmers. The decision to buy more soybeans from South America comes as Chicago Board of Trade soybean futures hover near five-year lows, with reduced Chinese buying expected to keep prices under pressure.
Advertisement
Neither the Chinese embassy in Washington nor the one in Brasília immediately responded to a request for comment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
3 minutes ago
- South China Morning Post
China needs to show it can compete on more than price
When policymakers start using internet slang to describe the economy, it is a sign something is not right. The word neijuan was once used by Chinese students to depict burnout from seemingly pointless competition. Now it is showing up in policy language, to explain the growing economic strain caused by China's price war. Advertisement Too much supply and weak demand are pushing prices down. The deflationary pressure is building not just on company profits, but on the growth model that China has relied on for decades. The Chinese government has been shifting towards a growth model driven by innovation since at least 2014. We are now seeing the results of that shift in sectors like electric vehicles, semiconductors and high-end manufacturing – where Chinese companies are no longer just competing on price, but leading on technology, production capacity and global market share. Still, the pressure to cut prices remains widespread, especially among firms that have yet to transition away from volume-led growth. The next phase of China's transformation depends on getting more companies to follow the lead of innovation powerhouses like BYD, Huawei, Haier and DeepSeek. That means moving beyond low-cost competition and continuing to build brands, invest in technology and deliver differentiated products and services. That shift will not be easy. The producer price index has been falling year on year since late 2022, fuelling a deflationary spiral. And while the economy grew 5.2 per cent in the second quarter this year, pricing power is now being eroded. 01:58 China GDP figures beat market forecasts despite looming US tariff risks China GDP figures beat market forecasts despite looming US tariff risks For years, many Chinese firms competed in overseas markets by offering cheaper goods. At home, where competition is fierce, the focus has been on scale and volume. This model worked reasonably well when demand was strong. But with global trade under pressure from tariffs and domestic spending still weak, production is outpacing demand.
South China Morning Post
3 minutes ago
- South China Morning Post
Innogen's shares almost quadruple in Hong Kong trading debut amid pharmaceutical bull run
Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China's pharmaceuticals sector, which has enjoyed rising valuations and solid performance. Trading under the stock code 2591, Innogen's shares first changed hands at HK$72 on Friday, almost four times more than the initial public offering (IPO) price of HK$18.68 despite a declining market. The city's benchmark Hang Seng index opened almost 1 per cent lower. The debut performance of the maker of drugs for diabetes and other metabolic diseases followed Chinese vaccine maker Ab&B Bio-Tech's 158 per cent gain on its first day of trading on Monday. The success of Innogen's share sale was bolstered by a rally in major biotech companies in Hong Kong, which gained an average of 137 per cent this year, according to a CCB International report on Wednesday. Investors were willing to pay more for each unit of sales in the sector as the price-to-sales ratio rose to 18.8 times from 8.7 times in December 2024. Innogen, which raised HK$683 million (US$87.2 million) through its IPO, followed peers that also took advantage of the Hong Kong exchange's Chapter 18A listing rule for pre-revenue biotech firms. These included Nanjing Leads Biolabs and TransThera Sciences, whose shares have jumped 88.3 per cent and 263.5 per cent, respectively, since their debuts this year. Innogen also emerged as one of the most popular IPOs among retail investors, as many were unable to successfully subscribe to the stock during the IPO stage, boosting sentiment for its debut.
South China Morning Post
33 minutes ago
- South China Morning Post
‘We're blowing everyone away': Trump shrugs off Latin American nations looking to China
US President Donald Trump on Thursday said he was not worried about Brazil Mexico and other Latin American nations moving closer to China, telling reporters in the Oval Office, 'They can do whatever they want.' Advertisement The remarks came during a brief exchange at the White House. Trump added: 'You know, none of them are doing very well, and what we're doing in terms of economics, we're blowing everyone away, including China. We're doing better than any other country in the world right now.' Trump's comments came as Brazil steps up coordination with Beijing to mount a multilateral response to the tariffs he imposed last month. On Tuesday, Brazilian President Luiz Inácio Lula da Silva spoke for about an hour by phone with Chinese leader Xi Jinping to discuss the 'Brics bloc's role in countering unilateral trade measures'. The call was arranged after Washington announced a 50 per cent tariff on a wide range of Brazilian exports in late July, threatening billions of dollars in trade. Chinese President Xi Jinping and his Brazilian counterpart Luiz Inácio Lula da Silva spoke by phone this week as the two nations step up coordination. Photo: AFP Trump has linked the tariffs to Brazil's political crisis, citing the criminal prosecution of former president Jair Bolsonaro on charges of plotting to overturn the 2022 election
